Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SJCRH pediatric brain tumors patient-derived orthotopic xenografts (PDOX) data

ABSTRACT: Data Access Committee EGAC00001002260

PROVIDER: EGAC00001002260 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource.

Project description: Not available

| S-EPMC7360541 | biostudies-literature

SJCRH Patient-derived orthotopic xenografts of pediatric brain tumors

Project description:Primary patient pediatric brain tumors from patients treated at SJCRH were implanted and amplified only in the brain of immunocompromised mice without tissue culture steps and referred as patient-derived orthotopic xenografts (Smith et al, Acta Neuropathologica, 2020).

| EGAS00001005533 | EGA

TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis.

Project description: Not available

| S-EPMC4480696 | biostudies-literature

Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors

Project description:Pediatric solid tumors arise from endodermal, ectodermal, or mesodermal lineages. Although the overall survival of children with solid tumors is 75%-80%, that of children with recurrent disease is below 30%. To capture the complexity and diversity of pediatric solid tumors and establish new models of recurrent disease, we developed a protocol to produce orthotopic patient-derived xenografts (O-PDXs) at diagnosis, recurrence, and autopsy. Tumor specimens were received from 168 patients, and 64 O-PDXs were established for 12 types of pediatric solid tumors. The origins of the O-PDX tumors were reflected in their gene-expression profiles and epigenomes. Genomic profiling of the tumors, including detailed clonal analysis, was performed to determine whether the clonal population in the xenograft recapitulated the patientÂ’s tumor. We identified several drug vulnerabilities and showed that the combination of a WEE1 inhibitor (AZD1775), irinotecan, and vincristine can lead to complete response in multiple rhabdomyosarcoma O-PDX tumors in vivo.

| EGAS00001002528 | EGA

Orthotopic patient-derived xenografts of paediatric solid tumours.

Project description: Not available

| S-EPMC5659286 | biostudies-literature

Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.

Project description: Not available

| S-EPMC7903462 | biostudies-literature

Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.

Project description: Not available

| S-EPMC5814265 | biostudies-literature

Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts.

Project description: Not available